Interstitial lung diseases are a group of conditions that cause scarring of the lungs. They can lead to sudden flare-ups, known as acute exacerbations. These flare-ups are particularly tough to manage in cases of idiopathic pulmonary fibrosis, a type of lung disease with an unknown cause. The outcome for patients experiencing these flare-ups is often grim, with a hig...

Scientists have unearthed a promising drug called GS-2278 that could potentially treat a condition known as idiopathic pulmonary fibrosis (IPF). IPF is a serious lung disease that causes scarring and makes it hard to breathe. The drug works by blocking a specific receptor in the body called LPAR1, which is involved in the fibrotic process. Initially, researchers fo...